Metformin usage and risk of endometrial cancer recurrence

Published: 12 September 2022| Version 1 | DOI: 10.17632/2948mwvk4k.1
Contributor:
Eav Lim

Description

Data set for patients with endometrial cancer, diabetes, metformin usage and treatment for the endometrial cancer

Files

Steps to reproduce

1. retrospective collection of data for patients diagnosed with endometrial cancer. data set collection to include, diabetes, metformin usage, stage of cancer, adjuvant therapy, and site of recurrence 2. categorical variables were computed to compare patients with recurrence of malignancy and their usage of metformin vs those that did not use metformin. 3. statistical analysis used with student-t-test, chi-square test. Fisher exact was used to compare frequency of recurrences. logistic regression model was used to help identify predictors of recurrence.

Institutions

WellSpan York Hospital

Categories

Endometrial Cancer, Diabetes Mellitus, Metformin

License